US Patent Issued to KITE PHARMA on April 22 for "Chimeric transmembrane proteins and uses thereof" (New York, California Inventors)

ALEXANDRIA, Va., June 6 -- United States Patent no. 12,280,119, issued on April 22, was assigned to KITE PHARMA INC. (Foster City, Calif.).

"Chimeric transmembrane proteins and uses thereof" was invented by Peter Emtage (Lafayette, Calif.) and Rosa Vincent (New York City, N.Y.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are chimeric transmembrane proteins, nucleic acids encoding these chimeric transmembrane proteins, and mammalian cells containing these nucleic acids, and methods of making and using these mammalian cells."

The patent was filed on March 21, 2019, under Application No. 17/040,009.

*For further information, including images, charts and tables, please visit: http://patft.usp...